The T1D Index

The first-of-its-kind index will raise awareness of the burden and unmet need of people living with type 1 diabetes around the world.

JDRF, the leading global type 1 diabetes (T1D) research and advocacy organisation, announces the launch of the Type 1 Diabetes Index (T1D Index). The T1D Index is a first-of-its-kind data simulation tool that measures the human and public health impact of the T1D crisis in every country across the globe.

Until now, there have been wide gaps in the data about the incidence and impact of T1D. Leveraging data and insights from the T1D Index can help change the lives of people living with T1D by identifying attainable country-by-country interventions including timely diagnosis, accessible care and funding research that could lead to cures.

The T1D Index and accompanying research has been published in the leading diabetes and endocrinology medical journal, The Lancet Diabetes & Endocrinology.

T1D is an autoimmune condition and one of the fastest-growing chronic health conditions, impacting nearly nine million people across the globe. Certain factors like family history can increase risk, but it is not caused by diet or lifestyle. T1D causes the pancreas to make very little insulin or none at all—this means the human body cannot convert food into energy, which can lead to long-term complications including damage to the kidneys, eyes, nerves, heart and even premature death. There is currently no cure for T1D. According to the Index, there are an estimated 18,126 people living with T1D in New Zealand.

“As a member of the T1D community, I know many are not as fortunate as I am to have the resources necessary to live a healthy and fulfilled life,” Aaron Kowalski, Ph.D., JDRF CEO, said. “This is why I am so proud that significant progress has been made to understand T1D’s global impact through the T1D Index. We are calling on government and public health decision makers throughout the world to utilise the tool to identify and implement interventions that can change the trajectory of T1D.”

JDRF collaborated with key partners and experts around the world to develop the T1D Index–using the results from a global survey of more than 500 endocrinologists and 400 publications to simulate the state of T1D globally and at the country level.

The Index uniquely illuminates the human burden of T1D by highlighting “missing people,” which is the number of people who would still be alive today if they had not died early due to complications from T1D, and “healthy years lost,” which represents time lost to ill-health, disability or early death from living with T1D.

Simulations from the T1D Index suggest that globally as of 2022 there are more than 3.86 million “missing people” and an average of 22 “healthy years lost” to T1D per person, if diagnosed at age 10.

Tom Robinson, VP Global Access for JDRF, played a key role in the development of the global T1D Index, says “we have been working on the T1D Index for some time, and its launch represents an important milestone for understanding the impact of type 1 diabetes globally.

“The data and insights we now have mean we can answer questions about how this condition affects populations around the globe, with that information hopefully informing decisions to support better outcomes for the type 1 diabetes community, regardless of country.”

Aaron Perry, Chair of JDRF New Zealand, noted that “In Aotearoa, we don’t actually have an accurate measure of how many people are diagnosed with Type 1 diabetes as it is not separated from Type 2 Diabetes, despite there being significant differences in the diseases. The T1D index reinforces the need to invest in finding a cure and providing access to drugs and devices that assist in the management of T1D. It is very clear: we can save lives and years.”

T1D has a profound human, emotional and financial burden for those who live with it–and prevalence is on the rise. Simulations from the T1D Index have led to the identification of four key interventions that could change the current trajectory for T1D and its impact on people around the world:

• Timely diagnosis: enabling better education and training for medical professionals to accurately diagnose T1D. If the global population has access to timely diagnosis from 2023, 668,000 more people could be alive in 2040.

• Insulin and strips: creating barrier-free access to insulin and blood glucose testing strips. If the global population has access to insulin and testing strips from 2023, and coaching to self-manage the condition, 1.98 million more people could be alive in 2040. Locally, this would restore 1.7 years of healthy years to NZ T1D’s.

• Pumps and CGMs: ensuring everyone living with T1D has access to technology that automates glucose monitoring and insulin delivery. 673,000 more people could be alive in 2040 if everyone with T1D has access to the technology available from 2023. Locally, this would restoring 6.1 years of healthy years to NZ T1D’s.

• Prevention and cures: making the case for further investment and research in emerging prevention, treatments and cures. 890,000 more people could be alive in 2040 if we find a cure.

Once interventions are identified on the global and country level, the T1D Index encourages users to take action by sharing the data and findings with their networks and local decision makers and connect with other T1D advocates in their communities.

Additionally, the T1D Index shines a light on important statistics about the burden of T1D globally, including:

• Since 2000, T1D prevalence has increased at four times the rate of global population growth.
• The expected number of people living with T1D in 2040 will be 17.43 million.
• The number of “missing people” in the year 2040 is projected to be 6.85 million.

The T1D Index data simulations are the best estimate currently available with version 1.0 testing to +/- 6 percent against real-world data. This is a significant improvement from leading existing estimates that test to +/- 35 percent against the same data.

It is a collaborative development by JDRF, Life for a Child, International Society for Pediatric and Adolescent Diabetes (ISPAD), International Diabetes Federation (IDF), and Beyond Type 1. The T1D Index is supported by founding corporate sponsor, Abbott Diabetes Care, with additional support from Lilly, Vertex Pharmaceuticals and The Leona M. and Harry B. Helmsley Charitable Trust.

In future releases, the Index will expand to include the impact of T1D on economic costs, mental health and quality of life. The data will also be broken down at regional and demographic levels.

You can learn more about the T1D Index here:

JDRF announces launch of global Type 1 Diabetes Index

JDRF launches Global Type 1 Diabetes Index

Type-1 Diabetes Index

New Zealand

Share this article...


Get our latest news direct to your inbox

More news stories

Time for Action

The Stats Don’t Lie!

There are 20,000 people in NZ living with type 1 diabetes. That means they have 120,000 family members, friends, and colleagues. That’s 1,700 per NZ

Read More »
Time for Action

T1D CGM – Access For All

On average people with T1D in Aotearoa NZ will lose 22 years¹ of healthy life. Lifesaving and life-changing technologies to measure blood glucose and deliver

Read More »